HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Thomas S Kilduff Selected Research
Thomas S Kilduff Research Topics
Disease
17
Narcolepsy
10/2023 - 07/2011
13
Cataplexy
10/2023 - 03/2013
7
Sleep Wake Disorders
10/2023 - 05/2014
5
Disorders of Excessive Somnolence (Hypersomnia)
01/2021 - 04/2015
5
Sleep Deprivation
01/2019 - 12/2002
4
Sleep Initiation and Maintenance Disorders (Insomnia)
09/2023 - 03/2010
3
Pain (Aches)
01/2017 - 01/2011
2
Nerve Degeneration
12/2022 - 11/2021
1
Sleepiness
01/2021
1
Cognitive Dysfunction
10/2020
1
Mental Disorders (Mental Disorder)
01/2018
1
Autism Spectrum Disorder
10/2017
1
Migraine Disorders (Migraine)
01/2017
1
Huntington Disease (Huntington's Disease)
02/2016
1
Lethargy
04/2015
1
Fragile X Syndrome (Martin Bell Syndrome)
04/2015
1
Body Weight (Weight, Body)
05/2014
1
Central Nervous System Diseases (CNS Diseases)
12/2012
1
Substance-Related Disorders (Drug Abuse)
07/2006
Drug/Important Bio-Agent (IBA)
20
Orexins
IBA
10/2023 - 07/2006
3
Antidepressive Agents (Antidepressants)
IBA
01/2019 - 04/2015
2
Peptides (Polypeptides)
IBA
10/2023 - 05/2014
2
trans-sodium crocetinate (crocetin)
IBA
01/2023 - 01/2023
2
Doxycycline (Periostat)
FDA Link
Generic
12/2022 - 05/2014
2
Neuropeptides
IBA
11/2021 - 01/2017
2
Neurotransmitter Agents (Neurotransmitter)
IBA
11/2021 - 01/2021
2
almorexant
IBA
10/2020 - 03/2013
2
Sodium Oxybate (gamma Hydroxybutyrate)
FDA Link
01/2019 - 01/2017
2
Ataxin-3
IBA
05/2014 - 03/2013
2
Diphtheria Toxin
IBA
05/2014 - 05/2014
1
Opioid Analgesics (Opioids)
IBA
09/2023
1
Vasoconstrictor Agents
IBA
01/2023
1
TAK-925
IBA
01/2023
1
Orexin Receptors
IBA
01/2021
1
Amines
IBA
01/2021
1
Biogenic Amines (Biogenic Amine)
IBA
01/2021
1
Biomarkers (Surrogate Marker)
IBA
01/2021
1
Zolpidem (Ambien)
FDA Link
Generic
10/2020
1
Methylphenidate (Ritalin)
FDA Link
Generic
01/2019
1
Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)
IBA
01/2019
1
Amphetamine (Amfetamine)
FDA Link
Generic
01/2019
1
Catecholamines
IBA
01/2019
1
Tricyclic Antidepressive Agents (Tricyclic Antidepressants)
IBA
01/2019
1
solriamfetol
IBA
01/2019
1
Norepinephrine (Noradrenaline)
FDA Link
Generic
01/2019
1
Modafinil (Provigil)
FDA Link
01/2019
1
pitolisant
IBA
01/2019
1
Serotonin (5 Hydroxytryptamine)
IBA
01/2019
1
Antipsychotic Agents (Antipsychotics)
IBA
01/2018
1
Trace amine-associated receptor 1
IBA
11/2017
1
4- (3- fluoro- 2- methylphenyl)- 4,5- dihydrooxazol- 2- ylamine
IBA
11/2017
1
Controlled Substances
IBA
11/2017
1
RO5256390
IBA
11/2017
1
neuroligin 3
IBA
10/2017
1
Eszopiclone (Lunesta)
FDA Link
01/2017
1
Dopamine (Intropin)
FDA Link
Generic
01/2017
1
Indicators and Reagents (Reagents)
IBA
02/2016
1
2- chloro- 4- (1- (4- fluorophenyl)- 2,5- dimethyl- 1H- imidazol- 4- ylethynyl)pyridine
IBA
04/2015
1
pyridine
IBA
04/2015
1
Baclofen
FDA Link
Generic
05/2014
1
Hypnotics and Sedatives (Sedatives)
IBA
03/2013
1
4- (3,4- dichlorophenyl)- 4,5- dihydrooxazol- 2- ylamine
IBA
12/2012
1
4-nitrophenethyl bromide (NPB)
IBA
01/2011
1
nelotanserin
IBA
03/2010
1
Urea (Carbamide)
FDA Link
Generic
03/2010
1
GABA-B Receptor Agonists
IBA
07/2006
1
GABA-B Receptors
IBA
07/2006
1
Calcium
IBA
07/2006
1
Messenger RNA (mRNA)
IBA
12/2002
1
Albumins
IBA
12/2002
1
Carrier Proteins (Binding Protein)
IBA
12/2002
Therapy/Procedure
5
Therapeutics
11/2021 - 05/2014
1
Aftercare (After-Treatment)
01/2023
1
Drug Therapy (Chemotherapy)
01/2019